FDA's Dickinson Named Acting Chief Counsel Following Tyler's Departure

摘要

FDA has tapped Elizabeth Dickinson for acting chief counsel, effective Aug. 7. Dickinson is taking the post on an interim basis while the agency seeks a permanent successor to Ralph Tyler. The agency announced June 30 that Tyler would be leaving FDA for personal health reasons.